Investing Profile

Christoph Broja

VCInvestor
Managing Director at EQT Life Sciences
Photo of Christoph Broja, Managing Director at EQT Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
EQT Life Sciences Managing Director
$11.0M - $65.0M
$25.0M
€260M
Board Member Cardior Pharmaceuticals2022 - Present
Managing Director EQT Life Sciences2022 - Present
Principal Gurnet Point Capital2021 - 2022
Board Observer Innocoll Biotherapeutics2020 - 2022
Board Member Tremeau Pharmaceuticals, Inc.2019 - 2022
Sr. Associate Gurnet Point Capital2016 - 2021
Board Observer Boston Pharmaceuticals2016 - 2021
Business Partner B-FLEXION2012 - 2016
Senior Analyst Franz Haniel & Cie. GmbH2010 - 2012